{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T09:52:04Z","timestamp":1772790724869,"version":"3.50.1"},"reference-count":37,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2010,7,1]],"date-time":"2010-07-01T00:00:00Z","timestamp":1277942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,7,1]],"date-time":"2010-07-01T00:00:00Z","timestamp":1277942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T00:00:00Z","timestamp":1653609600000},"content-version":"vor","delay-in-days":4348,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","fertstert.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Fertility and Sterility"],"published-print":{"date-parts":[[2010,7]]},"DOI":"10.1016\/j.fertnstert.2009.03.037","type":"journal-article","created":{"date-parts":[[2009,4,15]],"date-time":"2009-04-15T04:15:18Z","timestamp":1239768918000},"page":"666-672","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Increased plasma thrombin-activatable fibrinolysis inhibitor levels in young obese women with polycystic ovary syndrome"],"prefix":"10.1016","volume":"94","author":[{"given":"Ertan","family":"Adali","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Recep","family":"Yildizhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mertihan","family":"Kurdoglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guler","family":"Bugdayci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Kolusari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H. Guler","family":"Sahin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.fertnstert.2009.03.037_bib1","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1056\/NEJMra041536","article-title":"Polycystic ovary syndrome","volume":"352","author":"Ehrmann","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.fertnstert.2009.03.037_bib2","doi-asserted-by":"crossref","first-page":"4588","DOI":"10.1210\/jc.2003-031867","article-title":"Early impairment of endothelial structure and function in young normal-weight women with polycystic ovary syndrome","volume":"89","author":"Orio","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2009.03.037_bib3","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1161\/01.ATV.20.11.2414","article-title":"Evidence for association between polycystic ovary syndrome and premature carotid atherosclerosis in middle-aged women","volume":"20","author":"Talbott","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.fertnstert.2009.03.037_bib4","doi-asserted-by":"crossref","first-page":"987","DOI":"10.2459\/JCM.0b013e32830b58d4","article-title":"Cardiovascular risk in women with polycystic ovary syndrome","volume":"9","author":"Giallauria","year":"2008","journal-title":"J Cardiovasc Med"},{"key":"10.1016\/j.fertnstert.2009.03.037_bib5","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1055\/s-2007-992923","article-title":"Cardiovascular disease risk factors in polycystic ovary syndrome","volume":"26","author":"Dokras","year":"2008","journal-title":"Semin Reprod Med"},{"key":"10.1016\/j.fertnstert.2009.03.037_bib6","doi-asserted-by":"crossref","first-page":"36","DOI":"10.20452\/pamw.300","article-title":"Thrombin activatable fibrinolysis inhibitor and other hemostatic parameters in patients with essential arterial hypertension","volume":"118","author":"Malyszko","year":"2008","journal-title":"Pol Arch Med Wewn"},{"key":"10.1016\/j.fertnstert.2009.03.037_bib7","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1161\/01.ATV.20.9.2156","article-title":"Thrombin-activatable fibrinolysis inhibitor antigen levels and cardiovascular risk factors","volume":"20","author":"Juhan-Vague","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.fertnstert.2009.03.037_bib8","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1097\/00004872-200212000-00002","article-title":"Carotid intima-media thickness, arterial stiffness and risk of cardiovascular disease: current evidence","volume":"20","author":"Bots","year":"2002","journal-title":"J Hypertens"},{"key":"10.1016\/j.fertnstert.2009.03.037_bib9","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1016\/S0002-9378(96)70665-8","article-title":"Carotid atherosclerosis in women with polycystic ovary syndrome: initial results from a case-control study","volume":"174","author":"Guzick","year":"1996","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2009.03.037_bib10","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.atherosclerosis.2004.04.007","article-title":"Intima-media thickness of elastic and muscular arteries of young women with polycystic ovaries","volume":"175","author":"Lakhani","year":"2004","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.fertnstert.2009.03.037_bib11","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/humrep\/deh098","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)","volume":"19","year":"2004","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2009.03.037_bib12","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/0002-9378(81)90746-8","article-title":"Hirsutism: implications, etiology, and management","volume":"140","author":"Hatch","year":"1981","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2009.03.037_bib13","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"10.1016\/j.fertnstert.2009.03.037_bib14","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.atherosclerosis.2005.10.007","article-title":"Cardiovascular disease in the polycystic ovary syndrome: new insights and perspectives","volume":"185","author":"Cussons","year":"2006","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.fertnstert.2009.03.037_bib15","doi-asserted-by":"crossref","first-page":"3197","DOI":"10.1093\/humrep\/dem324","article-title":"Androgen excess is associated with the increased carotid intima-media thickness observed in young women with polycystic ovary syndrome","volume":"22","author":"Luque-Ramirez","year":"2007","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2009.03.037_bib16","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1080\/09513590600630447","article-title":"Are polycystic ovaries associated with cardiovascular disease risk as polycystic ovary syndrome?","volume":"22","author":"Engin-Ustun","year":"2006","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.fertnstert.2009.03.037_bib17","doi-asserted-by":"crossref","first-page":"4609","DOI":"10.1210\/jc.2007-1343","article-title":"Young obese women with polycystic ovary syndrome have evidence of early coronary atherosclerosis","volume":"92","author":"Shroff","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2009.03.037_bib18","doi-asserted-by":"crossref","first-page":"3871","DOI":"10.1210\/jcem.87.8.8716","article-title":"Global fibrinolytic capacity is decreased in polycystic ovary syndrome, suggesting a prothrombotic state","volume":"87","author":"Yildiz","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2009.03.037_bib19","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/S0015-0282(00)01614-9","article-title":"Are women with polycystic ovary syndrome resistant to activated protein C?","volume":"74","author":"Atiomo","year":"2000","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2009.03.037_bib20","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1046\/j.1365-2141.2003.04549.x","article-title":"Thrombin-activatable fibrinolysis inhibitor in young patients with myocardial infarction and its relationship with the fibrinolytic function and the protein C system","volume":"122","author":"Zorio","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1016\/j.fertnstert.2009.03.037_bib21","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1161\/01.STR.0000088642.07691.15","article-title":"Risk of ischemic stroke associated with functional thrombin-activatable fibrinolysis inhibitor plasma levels","volume":"34","author":"Santamaria","year":"2003","journal-title":"Stroke"},{"key":"10.1016\/j.fertnstert.2009.03.037_bib22","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1055\/s-2007-992118","article-title":"Thrombin-activatable fibrinolysis inhibitor and cardiovascular risk factors in polycystic ovary syndrome","volume":"116","author":"Erdogan","year":"2008","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.1016\/j.fertnstert.2009.03.037_bib23","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1080\/09513590802291824","article-title":"Increased thrombin-activatable fibrinolysis inhibitor antigen levels as a clue for prothrombotic state in polycystic ovary syndrome","volume":"24","author":"Karakurt","year":"2008","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.fertnstert.2009.03.037_bib24","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/S0015-0282(97)00486-X","article-title":"The plasminogen activator system in women with polycystic ovary syndrome","volume":"69","author":"Atiomo","year":"1998","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2009.03.037_bib25","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1046\/j.1538-7836.2003.00147.x","article-title":"Weak and non-independent association between plasma TAFI antigen levels and the insulin resistance syndrome","volume":"1","author":"Aubert","year":"2003","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.fertnstert.2009.03.037_bib26","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1210\/jcem.87.2.8214","article-title":"Insulin resistance is associated with increased circulating level of thrombin-activatable fibrinolysis inhibitor in type 2 diabetic patients","volume":"87","author":"Hori","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2009.03.037_bib27","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.diabres.2005.12.008","article-title":"Different metabolic correlations of thrombin-activatable fibrinolysis inhibitor and plasminogen activator inhibitor-1 in non-obese type 2 diabetic patients","volume":"73","author":"Kitagawa","year":"2006","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.fertnstert.2009.03.037_bib28","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1210\/jcem-61-5-946","article-title":"Lipoprotein lipid concentrations and cardiovascular risk in women with polycystic ovary syndrome","volume":"61","author":"Wild","year":"1985","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2009.03.037_bib29","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1046\/j.1365-2265.1996.674495.x","article-title":"Dyslipidaemia is associated with insulin resistance in women with polycystic ovaries","volume":"44","author":"Robinson","year":"1996","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.fertnstert.2009.03.037_bib30","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1055\/s-0037-1613349","article-title":"Thrombin activatable fibrinolysis inhibitor (TAFI) levels in patients with coronary artery disease investigated by angiography","volume":"88","author":"Schroeder","year":"2002","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.fertnstert.2009.03.037_bib31","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1002\/ajh.20108","article-title":"Association of functional thrombin-activatable fibrinolysis inhibitor (TAFI) with conventional cardiovascular risk factors and its correlation with other hemostatic factors in a Spanish population","volume":"76","author":"Santamaria","year":"2004","journal-title":"Am J Hematol"},{"key":"10.1016\/j.fertnstert.2009.03.037_bib32","first-page":"424","article-title":"The role of thrombin activatable fibrinolysis inhibitor in disturbances of fibrinolytic system in obesity","volume":"113","author":"Ko\u0142acz","year":"2005","journal-title":"Pol Arch Med Wewn"},{"key":"10.1016\/j.fertnstert.2009.03.037_bib33","doi-asserted-by":"crossref","first-page":"6061","DOI":"10.1210\/jc.2003-032110","article-title":"The relationship between C-reactive protein and carotid intima-media wall thickness in middle-aged women with polycystic ovary syndrome","volume":"89","author":"Talbott","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2009.03.037_bib34","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1093\/humrep\/dei100","article-title":"Evaluation of metabolic syndrome frequency and premature carotid atherosclerosis in young women with polycystic ovary syndrome","volume":"20","author":"Vural","year":"2005","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2009.03.037_bib35","doi-asserted-by":"crossref","first-page":"5711","DOI":"10.1210\/jc.2005-0011","article-title":"Overweight women with polycystic ovary syndrome have evidence of subclinical cardiovascular disease","volume":"90","author":"Meyer","year":"2005","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2009.03.037_bib36","doi-asserted-by":"crossref","first-page":"5092","DOI":"10.1210\/jc.2002-020703","article-title":"Low insulin sensitivity measured by both quantitative insulin sensitivity check index and homeostasis model assessment method as a risk factor of increased intima-media thickness of the carotid artery","volume":"87","author":"Rajala","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2009.03.037_bib37","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1097\/01.CCM.0000126361.00450.B1","article-title":"Thrombin activatable fibrinolysis inhibitor: not just an inhibitor of fibrinolysis","volume":"32","author":"Bajzar","year":"2004","journal-title":"Crit Care Med"}],"container-title":["Fertility and Sterility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028209006025?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028209006025?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T07:45:07Z","timestamp":1758008707000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0015028209006025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,7]]}},"alternative-id":["S0015028209006025"],"URL":"https:\/\/doi.org\/10.1016\/j.fertnstert.2009.03.037","relation":{},"ISSN":["0015-0282"],"issn-type":[{"value":"0015-0282","type":"print"}],"subject":[],"published":{"date-parts":[[2010,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Increased plasma thrombin-activatable fibrinolysis inhibitor levels in young obese women with polycystic ovary syndrome","name":"articletitle","label":"Article Title"},{"value":"Fertility and Sterility","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fertnstert.2009.03.037","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}